D-0854-2018 Class II Terminated

Recalled by PharMEDium Services, LLC — Dayton, NJ

FDA drug recall D-0854-2018 was initiated by PharMEDium Services, LLC on Jun 5, 2018 and is designated Class II. Reason for recall: Superpotent and Subpotent The recall status is terminated (terminated Feb 6, 2019). Affected quantity: 2,800 syringes.

Recall Details

Product Type
Drugs
Report Date
Jun 20, 2018
Initiation Date
Jun 5, 2018
Termination Date
Feb 6, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,800 syringes

Product Description

HYDROmorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride, 1 mL Total Volume in 3 mL syringe, Rx, PharMEDium Services, LLC, Dayton, NJ

Reason for Recall

Superpotent and Subpotent

Distribution Pattern

Nationwide

Code Information

Lot numbers: 180820005D, exp 6/21/2018; 180990007D, exp 7/8/2018; and 181000020D, exp 7/9/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0854-2018
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.